Koh Youngil I, Choi Inseon S
Division of Allergy, Department of Internal Medicine, Chonnam National University Medical School and Research Institute of Medical Science, Kwangju, South Korea.
Int Arch Allergy Immunol. 2002 Dec;129(4):341-7. doi: 10.1159/000067593.
The nasal and bronchial mucosa present similarities and most patients with asthma also have rhinitis, suggesting the concept of 'one airway one disease'. Although many studies may suggest the relationship between nasal and bronchial responsiveness in patients with allergic rhinitis and asthma, few studies have been published which address this question directly. The aim of this study is to investigate whether the relationship between nonspecific nasal and bronchial responsiveness exists in perennial allergic rhinitic patients with asthma.
Fifty-one perennial allergic rhinitic patients with the definitive or suspected asthma underwent methacholine bronchial provocation tests and nasal histamine challenge tests. A slope of the absolute changes in nasal symptoms score/log concentrations of histamine was calculated by linear regression analysis. A ratio of the final absolute change in nasal symptoms score to the sum of all the doses of histamine given to the subject was also calculated. The degree of bronchial responsiveness to methacholine was categorized as positive bronchial hyperresponsiveness (BHR) if PC(20) (provocative concentration of methacholine resulting in 20% fall in FEV(1)) was <4 mg/ml, borderline BHR if PC(20) was >or=4 but <or=16 mg/ml, and negative BHR if PC(20) was >16 mg/ml. Another index of bronchial responsiveness (BRindex) was calculated as the log [(% decline in FEV(1)/log final methacholine concentration as mg/dl) + 10].
The geometric means of the slope (4.47 vs. 2.95, p < 0.05) and the ratio (1.68 vs. 0.54, p < 0.01) were higher in patients with positive BHR (n = 23) than in patients with negative BHR (n = 19), respectively. The geometric means of the slope (3.50) and the ratio (1.13) in patients with borderline BHR (n = 9) were between the two groups, respectively. In all patients, the log-slope (r = 0.48, p < 0.001) and the log-ratio (r = 0.51, p < 0.001) were correlated well with the BRindex, respectively. Even in allergic rhinitic patients with definitive asthma, the log-slope was correlated with the BRindex (r = 0.39, p < 0.05) or log-PC(20) (r = -0.36, p < 0.05).
The nonspecific nasal responsiveness may be related to the nonspecific bronchial responsiveness in patients with allergic rhinitis and asthma, which may support the viewpoint that allergic rhinitis and asthma represent a continuum of inflammation involving one common airway.
鼻黏膜和支气管黏膜存在相似性,且大多数哮喘患者也患有鼻炎,这提示了“同一气道,同一疾病”的概念。尽管许多研究可能表明变应性鼻炎和哮喘患者鼻和支气管反应性之间的关系,但很少有直接针对该问题的研究发表。本研究的目的是调查常年性变应性鼻炎合并哮喘患者中是否存在非特异性鼻和支气管反应性之间的关系。
51例确诊或疑似哮喘的常年性变应性鼻炎患者接受了乙酰甲胆碱支气管激发试验和鼻组胺激发试验。通过线性回归分析计算鼻症状评分的绝对变化斜率/组胺对数浓度。还计算了鼻症状评分的最终绝对变化与给予受试者的所有组胺剂量总和的比值。如果PC(20)(导致第一秒用力呼气容积(FEV₁)下降20%的乙酰甲胆碱激发浓度)<4mg/ml,则将对乙酰甲胆碱的支气管反应性程度分类为阳性支气管高反应性(BHR);如果PC(20)≥4但≤16mg/ml,则为临界BHR;如果PC(20)>16mg/ml,则为阴性BHR。另一个支气管反应性指标(BR指数)计算为log [(FEV₁下降百分比/log最终乙酰甲胆碱浓度(mg/dl))+10]。
阳性BHR患者(n = 23)的斜率几何均值(4.47对2.95,p < 0.05)和比值几何均值(1.68对0.54,p < 0.01)分别高于阴性BHR患者(n = 19)。临界BHR患者(n = 9)的斜率几何均值(3.50)和比值几何均值(1.13)分别介于两组之间。在所有患者中,对数斜率(r = 0.48,p < 0.001)和对数比值(r = 0.51,p < 0.001)分别与BR指数密切相关。即使在确诊哮喘的变应性鼻炎患者中,对数斜率也与BR指数(r = 0.39,p < 0.05)或对数PC(20)(r = -0.36,p < 0.05)相关。
变应性鼻炎和哮喘患者的非特异性鼻反应性可能与非特异性支气管反应性相关,这可能支持变应性鼻炎和哮喘代表涉及一个共同气道的连续炎症这一观点。